Market News

Roth Capital Reconfirms Ceva (CEVA) As “Buy”; Has Price Objective Of $53.0; Cigna (CI) Covered By 15 Bulls

Among 10 analysts covering Ceva (NASDAQ:CEVA), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ceva has $5400 highest and $22 lowest target. $37.78’s average target is -17.51% below currents $45.8 stock price. Ceva had 25 analyst reports since July 31, 2015 according to SRatingsIntel. Benchmark maintained the shares of CEVA in report on Tuesday, November 10 with “Buy” rating. Chardan Capital Markets maintained it with “Buy” rating and $27 target in Tuesday, November 3 report. Oppenheimer maintained it with “Outperform” rating and $25 target in Tuesday, November 3 report. Canaccord Genuity maintained the shares of CEVA in report on Monday, August 14 with “Buy” rating. The stock of CEVA, Inc. (NASDAQ:CEVA) has “Buy” rating given on Monday, July 10 by Canaccord Genuity. The stock of CEVA, Inc. (NASDAQ:CEVA) has “Buy” rating given on Tuesday, October 3 by Canaccord Genuity. The company was downgraded on Tuesday, November 10 by Wunderlich. Canaccord Genuity maintained the shares of CEVA in report on Thursday, November 2 with “Buy” rating. The company was maintained on Wednesday, November 1 by Benchmark. As per Thursday, September 29, the company rating was initiated by Roth Capital.

Among 18 analysts covering CIGNA (NYSE:CI), 15 have Buy rating, 0 Sell and 3 Hold. Therefore 83% are positive. CIGNA had 52 analyst reports since July 27, 2015 according to SRatingsIntel. Credit Suisse initiated the shares of CI in report on Friday, November 3 with “Buy” rating. As per Monday, October 23, the company rating was maintained by Cowen & Co. As per Wednesday, January 6, the company rating was maintained by Barclays Capital. The stock of Cigna Corporation (NYSE:CI) has “Overweight” rating given on Thursday, August 17 by Morgan Stanley. The rating was maintained by UBS on Monday, June 5 with “Buy”. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, June 22. The firm has “Buy” rating by Jefferies given on Friday, October 13. The rating was initiated by Evercore with “Hold” on Friday, September 23. The firm has “Buy” rating by Piper Jaffray given on Sunday, August 6. The stock has “Overweight” rating by Morgan Stanley on Wednesday, June 7. See Cigna Corporation (NYSE:CI) latest ratings:

03/11/2017 Broker: Credit Suisse Rating: Buy New Target: $219.0 Initiate
03/11/2017 Broker: Citigroup Rating: Buy Old Target: $198 New Target: $231 Maintain
03/11/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $195 New Target: $223 Maintain
03/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $220.0 Maintain
02/11/2017 Broker: Jefferies Rating: Buy New Target: $231.0 Maintain
31/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $191.0 Maintain
23/10/2017 Broker: Cowen & Co Rating: Buy New Target: $185.0 Maintain
17/10/2017 Broker: BMO Capital Markets Rating: Market Perform New Target: $210 Initiates Coverage On
12/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $185.0 Maintain
13/10/2017 Broker: Jefferies Rating: Buy Old Target: $201 New Target: $221 Maintain

Cigna Corporation, a health services organization, provides insurance and related services and products in the United States and internationally. The company has market cap of $50.88 billion. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations divisions. It has a 22.6 P/E ratio. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other services and products to insured and self-insured customers.

Investors sentiment is 0.96 in 2017 Q2. Its the same as in 2017Q1. It is the same, as 48 investors sold Cigna Corporation shares while 245 reduced holdings. only 81 funds opened positions while 200 raised stakes. 217.98 million shares or 0.25% less from 218.52 million shares in 2017Q1 were reported. Commonwealth Equity Serv, Massachusetts-based fund reported 38,748 shares. Manufacturers Life The owns 264,817 shares or 0.05% of their US portfolio. Alpha Windward Ltd Limited Liability Company has invested 0.02% in Cigna Corporation (NYSE:CI). Guggenheim Cap Limited Liability Company holds 0.14% in Cigna Corporation (NYSE:CI) or 322,560 shares. State Of Alaska Department Of Revenue reported 5,549 shares or 0.06% of all its holdings. 2,371 were reported by Pitcairn. First Midwest Fincl Bank Tru Division reported 1,905 shares. Thomas White Limited holds 0.07% or 2,600 shares in its portfolio. Fdx Advisors Inc invested in 0.02% or 4,018 shares. Parkwood Limited Liability has invested 0.04% of its portfolio in Cigna Corporation (NYSE:CI). Qci Asset Mngmt New York has 0% invested in Cigna Corporation (NYSE:CI). The New York-based Goldman Sachs Group has invested 0.08% in Cigna Corporation (NYSE:CI). New Mexico Educational Retirement Board, New Mexico-based fund reported 23,803 shares. Barrow Hanley Mewhinney & Strauss Ltd Liability Co holds 1.98 million shares or 0.5% of its portfolio. Employees Retirement Of Ohio holds 0.16% of its portfolio in Cigna Corporation (NYSE:CI) for 169,750 shares.

The stock increased 1.06% or $2.1625 during the last trading session, reaching $206.3725. About 197,046 shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since December 7, 2016 and is uptrending. It has outperformed by 6.87% the S&P500.

Since June 13, 2017, it had 0 buys, and 2 insider sales for $560,422 activity. Triplett Michael W had sold 1,439 shares worth $240,153. Another trade for 1,923 shares valued at $320,269 was made by ZOLLARS WILLIAM D on Tuesday, June 13.

Analysts await CEVA, Inc. (NASDAQ:CEVA) to report earnings on February, 7. They expect $0.13 EPS, down 48.00% or $0.12 from last year’s $0.25 per share. CEVA’s profit will be $2.86M for 88.08 P/E if the $0.13 EPS becomes a reality. After $0.27 actual EPS reported by CEVA, Inc. for the previous quarter, Wall Street now forecasts -51.85% negative EPS growth.

CEVA, Inc. licenses signal processing intellectual property technologies to semiconductor companies and original equipment manufacturers (OEMs) serving the mobile, consumer, automotive, industrial, and Internet-of Things (IoT) markets worldwide. The company has market cap of $1.01 billion. The firm licenses a family of programmable digital signal processor (DSP) cores and application-specific platforms for vision, imaging, and audio and voice, as well as long and short range wireless technologies, Wi-Fi, Bluetooth IPs, Serial ATA, and Serial Attached SCSI. It has a 60.58 P/E ratio. The Company’s technologies are licensed to semiconductor and OEM companies in the form of IP, which is used for the design, manufacture, market, and sale of application-specific integrated circuits and application-specific standard products to wireless, consumer electronics, and automotive companies for incorporation into a variety of end products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *